Nationwide Recall Issued for Thyroid Tablets USP 30 mg Lot 504950
Vitruvias Therapeutics recalled one batch after lab testing indicated the tablets could be over-potent.
What Happened
More than 3,600 bottles of Thyroid Tablets, USP 30 mg are being recalled nationwide after lab testing showed the pills could be too strong, according to the source report.
Vitruvias Therapeutics initiated a voluntary recall for a single batch of Thyroid Tablets, USP 30 mg. The recall applies to lot number 504950 with an expiration date of Sept. 30, 2026, and National Drug Code (NDC) 69680-166-00.
- Product: Thyroid Tablets, USP 30 mg
- Lot: 504950
- Expiration date: Sept. 30, 2026
- NDC: 69680-166-00
What The Evidence Shows
The evidence described in the report is laboratory testing indicating potential over-potency in the recalled lot, rather than a clinical study in patients.
The report says Vitruvias Therapeutics confirmed that no adverse health events or side effects linked to the recall had been reported as of late August.
- Evidence type: lab testing on tablets from one lot
- Clinical outcomes: no adverse events reported as of late August (per the company)
Why Over-Potent Thyroid Tablets Matter For Metabolic Health
The report notes that thyroid medication that is too strong can trigger hyperthyroidism, meaning too much thyroid hormone in the body.
Potential warning signs listed in the report include sudden weight loss, muscle weakness, severe fatigue, nervousness, high blood pressure, and heat intolerance. More severe cases may involve chest pain, rapid heart rate, or dangerous heart rhythm disruptions.
- Potential risk described: hyperthyroidism from excess thyroid hormone exposure
- Possible severe complications listed: chest pain, rapid heart rate, dangerous rhythm disruptions
Who The Report Flags As Higher Risk
The report states that older patients, pregnant women, and infants are most prone to health risks from excess thyroid medication.
For people in these groups, the concern is not only symptoms like nervousness or heat intolerance, but also the more severe cardiac symptoms described in the report.
- Higher-risk groups named in the report: older patients, pregnant women, infants
What To Do If You Have This Lot
The report advises that anyone taking the affected thyroid pills should contact their physician right away for guidance.
The report also lists company contact details for consumers with questions about the safety alert: 256-239-9373 (Monday through Friday, 9 a.m. to 5 p.m. CT) and safety@vitruvias.com.
- Physician contact advised in the report for affected patients
- Company contact in the report: 256-239-9373; safety@vitruvias.com
How to test thyroid at home
You don't need a lab appointment to check your own thyroid — a few at-home kits mail you a collection kit and return physician-reviewed results online within days:
Prefer to order direct? The Everlywell Thyroid Test uses a CLIA-certified lab, physician-reviewed results, and prepaid return shipping.
What Makes a Good Selenium Supplement
Selenium is studied in thyroid health, typically ~200 mcg/day as selenomethionine. It has a narrow safe range — more is not better, and long-term high doses can be harmful — so don't stack multiple products, and never add iodine without testing. Pick a modest, third-party-tested dose.
Related Articles
Menopause Does Not Drive Midlife Aortic Stiffness in Women
A study in Hypertension reveals aortic stiffening and rising pulse pressure in women start in...
Read article HormonesHormone Therapy Linked to Fewer Mood Disturbances in Menopause Study
A study in Menopause found hormone therapy initiated for vasomotor symptoms reduced severe mood...
Read article HormonesHormone Therapy Cardiovascular Risk Lower in SWAN Study
A 20-year observational study linked menopausal hormone therapy with 22% lower cardiovascular...
Read article HormonesMenopause Documentation Is Rare in Health Records
A study of nearly 396,000 women found menopause in about 7% of electronic health records, far...
Read articlePartner · Opt Health
Want your hormones actually worked up?
Opt Health is a longevity-medicine practice that runs a 55+ biomarker panel — full thyroid, testosterone, estradiol, SHBG, cortisol — and reviews it one-on-one with a physician who treats hormones for a living.
See how Opt Health treats hormones →Topic updates
Get the weekly hormone optimization roundup
Testosterone, thyroid, cortisol, estrogen, menopause, perimenopause, libido, and hormone testing.
Understand Your Health Better
Our free assessment maps your symptoms to the most relevant guides, tools, and product recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Affiliate disclosure: The Metabolic Journal is reader-supported. Some links above are affiliate or referral links and we may earn a commission at no extra cost to you. Products are chosen on the merits; commissions never influence what we recommend. This is general information, not medical advice — talk to your clinician before acting.